Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jitu Halder, Deepak Pradhan, Prativa Biswasroy, Vineet Kumar Rai, Biswakanth Kar, Goutam Ghosh & Goutam Rath. (2022) Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer. Journal of Drug Targeting 30:10, pages 1055-1075.
Read now
Read now
Heng Liu, Xiao Chen, Wei Xue, Chengchao Chu, Yu Liu, Haipeng Tong, Xuesong Du, Tian Xie, Gang Liu & Weiguo Zhang. (2016) Recombinant epidermal growth factor-like domain-1 from coagulation factor VII functionalized iron oxide nanoparticles for targeted glioma magnetic resonance imaging. International Journal of Nanomedicine 11, pages 5099-5108.
Read now
Read now
Shijun Zhu, Walter Kisiel, Yang J. Lu, Lars C. Petersen, John M. Ndungu, Terry W. Moore, Ernest T. Parker, Aiming Sun, Jann N. Sarkaria, James P. Snyder, Dennis C. Liotta, Daniel J. Brat, Bassel F. El-Rayes & Mamoru Shoji. (2015) Visualizing cancer and response to therapy in vivo using Cy5.5-labeled factor VIIa and anti-tissue factor antibody. Journal of Drug Targeting 23:3, pages 257-265.
Read now
Read now
Articles from other publishers (33)
Iliyana Sazdova, Milena Keremidarska-Markova, Daniela Dimitrova, Vadim Mitrokhin, Andre Kamkin, Nikola Hadzi-Petrushev, Jane Bogdanov, Rudolf Schubert, Hristo Gagov, Dimiter Avtanski & Mitko Mladenov. (2023) Anticarcinogenic Potency of EF24: An Overview of Its Pharmacokinetics, Efficacy, Mechanism of Action, and Nanoformulation for Drug Delivery. Cancers 15:22, pages 5478.
Crossref
Crossref
Diptasree Mukherjee & Arunkumar Krishnan. (2023) Therapeutic potential of curcumin and its nanoformulations for treating oral cancer. World Journal of Methodology 13:3, pages 29-45.
Crossref
Crossref
Mohammad-Nabil Savari & Ali JabaliMohammad-Nabil Savari & Ali Jabali. 2023. Theranostic Iron-Oxide Based Nanoplatforms in Oncology. Theranostic Iron-Oxide Based Nanoplatforms in Oncology
129
240
.
Adeoluwa Adeluola, Abu Hasanat Md Zulfiker, Daniel Brazeau & A.R.M. Ruhul Amin. (2021) Perspectives for synthetic curcumins in chemoprevention and treatment of cancer: An update with promising analogues. European Journal of Pharmacology 906, pages 174266.
Crossref
Crossref
Yonghan He, Wen Li, Guangrong Hu, Hui Sun & Qingpeng Kong. (2018) Bioactivities of EF24, a Novel Curcumin Analog: A Review. Frontiers in Oncology 8.
Crossref
Crossref
Xiu-Fen Liu, Ji-Long Hao, Tian Xie, Nour Jama Mukhtar, Wiley Zhang, Tayyab Hamid Malik, Cheng-Wei Lu & Dan-Dan Zhou. (2017) Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review. Frontiers in Pharmacology 8.
Crossref
Crossref
Carsten H. Nielsen, Troels E. Jeppesen, Lotte K. Kristensen, Mette M. Jensen, Henrik H. El Ali, Jacob Madsen, Bo Wiinberg, Lars C. Petersen & Andreas Kjaer. (2016)
PET Imaging of Tissue Factor in Pancreatic Cancer Using
64
Cu-Labeled Active Site–Inhibited Factor VII
. Journal of Nuclear Medicine 57:7, pages 1112-1119.
Crossref
Crossref
Brian Adams, Marike Herold, Eva Ferstl, Jungwhan Choi & Shijun Zhu. (2015) Anticancer effects of monocarbonyl analogs of curcumin: oxidative stress, nuclear translocation and modulation of AP-1 and NF-κB. International Journal of Cancer Therapy and Oncology 3:2, pages 3219.
Crossref
Crossref
Dinesh Shetty, Yong Kim, Hyunsuk Shim & James Snyder. (2014) Eliminating the Heart from the Curcumin Molecule: Monocarbonyl Curcumin Mimics (MACs). Molecules 20:1, pages 249-292.
Crossref
Crossref
Shijun Zhu, Walter Kisiel, Yang J. Lu, Lars C. Petersen, John M. Ndungu, Terry W. Moore, Ernest T. Parker, Aiming Sun, Dennis C. Liotta, Bassel F. El-Rayes, Daniel J. Brat, James P. Snyder & Mamoru Shoji. (2014) Tumor Angiogenesis Therapy Using Targeted Delivery of Paclitaxel to the Vasculature of Breast Cancer Metastases. Journal of Drug Delivery 2014, pages 1-12.
Crossref
Crossref
Joel M. Reid, Sarah A. Buhrow, Judith A. Gilbert, Lee Jia, Mamoru Shoji, James P. Snyder & Matthew M. Ames. (2014) Mouse pharmacokinetics and metabolism of the curcumin analog, 4-piperidinone,3,5-bis[(2-fluorophenyl)methylene]-acetate(3E,5E) (EF-24; NSC 716993). Cancer Chemotherapy and Pharmacology 73:6, pages 1137-1146.
Crossref
Crossref
Shiro Koizume. (2014) Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets. World Journal of Clinical Oncology 5:5, pages 908.
Crossref
Crossref
QING ZHANG, XIUJUN LIU, CAIHONG LI, DONGSHENG LIAO, ZHIGANG OUYANG, JUNNIAN ZHENG & XU SONG. (2013) Tissue factor-targeted lidamycin inhibits growth and metastasis of colon carcinoma. Oncology Letters 6:3, pages 801-806.
Crossref
Crossref
Inder Lal, Kim Dittus & Chris E Holmes. (2013) Platelets, coagulation and fibrinolysis in breast cancer progression. Breast Cancer Research 15:4.
Crossref
Crossref
Belinda J Cridge, Lesley Larsen & Rhonda J Rosengren. (2013) Curcumin and its derivatives in breast cancer: Current developments and potential for the treatment of drug-resistant cancers. Oncology Discovery 1:1, pages 6.
Crossref
Crossref
Haitao Liu, Yingjian Liang, Luoluo Wang, Lantian Tian, Ruipeng Song, Tianwen Han, Shangha Pan & Lianxin Liu. (2012) In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin Analog. PLoS ONE 7:10, pages e48075.
Crossref
Crossref
Ganji Purnachandra Nagaraju, Sheik Aliya, Syed F. Zafar, Riyaz Basha, Roberto Diaz & Bassel F. El-Rayes. (2012) The impact of curcumin on breast cancer. Integrative Biology 4:9, pages 996-1007.
Crossref
Crossref
Qing ZhangXiujun LiuShuangshuang XuCaihong LiYang ZhangJie YangJunnian Zheng. (2012) Factor VII Light Chain-Targeted Lidamycin Shows Intensified Therapeutic Efficacy for Liver Cancer. Cancer Biotherapy and Radiopharmaceuticals 27:6, pages 384-391.
Crossref
Crossref
Shijun Zhu, Terry W. Moore, Xiaoqian Lin, Nao Morii, Alessandra Mancini, Randy B. Howard, Deborah Culver, Richard F. Arrendale, Prabhakar Reddy, Taylor J. Evers, Hongzheng Zhang, Gabriel Sica, Zhuo G. Chen, Aiming Sun, Haian Fu, Fadlo R. Khuri, Dong M. Shin, James P. Snyder & Mamoru Shoji. (2012) Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts. Integrative Biology 4:6, pages 633-640.
Crossref
Crossref
Amarnadh Nalla, Inge Buch, Maibritt Sigvardt, Rasmus Poul Bodholdt, Andreas Kjaer & Birger Hesse. (2012)
111
Indium Labelling of Recombinant Activated Coagulation Factor VII: In Vitro and Preliminary In Vivo Studies in Healthy Rats
. International Journal of Molecular Imaging 2012, pages 1-7.
Crossref
Crossref
Tamara Minko. 2012. Fundamentals and Applications of Controlled Release Drug Delivery. Fundamentals and Applications of Controlled Release Drug Delivery
329
355
.
Chengcheng Xu, Qi Gui, Wenshu Chen, Leiming Wu, Wei Sun, Ni Zhang, Qinzi Xu, Jianing Wang & Xiangning Fu. (2011) Small interference RNA targeting tissue factor inhibits human lung adenocarcinoma growth in vitro and in vivo. Journal of Experimental & Clinical Cancer Research 30:1.
Crossref
Crossref
J Duanmu, J Cheng, J Xu, C J Booth & Z Hu. (2011) Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy. British Journal of Cancer 104:9, pages 1401-1409.
Crossref
Crossref
Zhiwei Hu, Benqiang Rao, Shimin Chen & Jinzhong Duanmu. (2010) Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer. Breast Cancer Research and Treatment 126:3, pages 589-600.
Crossref
Crossref
Murielle Mimeault & Surinder K Batra. (2011) Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chinese Medicine 6:1, pages 31.
Crossref
Crossref
Zhiwei Hu, Benqiang Rao, Shimin Chen & Jinzhong Duanmu. (2010) Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivoin mice. BMC Cancer 10:1.
Crossref
Crossref
Xin Tan, Neil Sidell, Alessandra Mancini, Ruo-Pan Huang, Shenming Wang, Ira R. Horowitz, Dennis C. Liotta, Robert N. Taylor & Friedrich Wieser. (2010) Multiple Anticancer Activities of EF24, a Novel Curcumin Analog, on Human Ovarian Carcinoma Cells. Reproductive Sciences 17:10, pages 931-940.
Crossref
Crossref
Ravi Shankar Prasad Singh, Umashankar Das, Jonathan R. Dimmock & Jane Alcorn. (2010) A general HPLC–UV method for the quantitative determination of curcumin analogues containing the 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore in rat biomatrices. Journal of Chromatography B 878:28, pages 2796-2802.
Crossref
Crossref
John M. Ndungu, Yang J. Lu, Shijun Zhu, Chao Yang, Xu Wang, Georgia Chen, Dong M. Shin, James P. Snyder, Mamoru Shoji & Aiming Sun. (2010) Targeted Delivery of Paclitaxel to Tumor Cells: Synthesis and in Vitro Evaluation. Journal of Medicinal Chemistry 53:8, pages 3127-3132.
Crossref
Crossref
Igor Landais, Sanne Hiddingh, Matthew McCarroll, Chao Yang, Aiming Sun, Mitchell S Turker, James P Snyder & Maureen E Hoatlin. (2009) Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors. Molecular Cancer 8:1.
Crossref
Crossref
Shiro Koizume, Naho Yokota, Etsuko Miyagi, Fumiki Hirahara, Yoshiyasu Nakamura, Yuji Sakuma, Akira Yoshida, Yoichi Kameda, Eiju Tsuchiya, Wolfram Ruf & Yohei Miyagi. (2009) Hepatocyte Nuclear Factor-4–Independent Synthesis of Coagulation Factor VII in Breast Cancer Cells and Its Inhibition by Targeting Selective Histone Acetyltransferases. Molecular Cancer Research 7:12, pages 1928-1936.
Crossref
Crossref
M. Provencal, D. Labbe, R. Veitch, D. Boivin, G.-E. Rivard, H. Sartelet, Y. Robitaille, D. Gingras & R. Beliveau. (2009) c-Met activation in medulloblastoma induces tissue factor expression and activity: effects on cell migration. Carcinogenesis 30:7, pages 1089-1096.
Crossref
Crossref
Frederick R. Rickles & Anna Falanga. 2009. Coagulation in Cancer. Coagulation in Cancer
31
41
.